Telmisartan And Hydrochlorthiazide
NDC Package 13668-159-74

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Telmisartan And Hydrochlorthiazide is a . Marketed by Torrent Pharmaceuticals Limited, this product is identified by NDC 13668-159 and is authorized under FDA application ANDA201192.

Identification & Billing

NDC Package Code
13668-159-74
Package Description
100 TABLET in 1 CARTON
Product Code
11-Digit Billing Format
13668015974

Clinical Specifications

Proprietary Name
Telmisartan And Hydrochlorthiazide
Dosage Form
-

Regulatory & Marketing

Labeler Name
Torrent Pharmaceuticals Limited
FDA Application #
ANDA201192
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
02-25-2014
End Marketing Date
01-31-2022
Listing Expiration
01-31-2022
Exclude Flag
D
Sample Package
No

Hierarchy Structure

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (13668-159). Click a package code to view its specific billing and regulatory data.

100 TABLET in 1 BOTTLE
30 TABLET in 1 BOTTLE
30 TABLET in 1 CARTON

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 13668-159-74 identifies a specific commercial package of 100 tablet in 1 carton of Telmisartan And Hydrochlorthiazide, labeled by Torrent Pharmaceuticals Limited. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Torrent Pharmaceuticals Limited on February 25, 2014. The current certification is valid through January 31, 2022.

How is this Torrent Pharmaceuticals Limited product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 13668015974. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
13668-159-74
11-Digit CMS (5-4-2)
13668-0159-74

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.